Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Frank, Begrow"'
Publikováno v:
Molecules, Vol 27, Iss 19, p 6622 (2022)
Extracts from Drosera rotundifolia are traditionally used to treat cough symptoms during a common cold. The present study aimed to investigate the impact of extracts from D. rotundifolia and active compounds on the respiratory tract. Tracheal slices
Externí odkaz:
https://doaj.org/article/e5345eeb58d444cfad8749919f1ea391
Autor:
Frank Begrow, Eugen J. Verspohl
Publikováno v:
Pharmacology & Pharmacy. :176-181
Cystic fibrosis is a life-threatening, wide spread genetic disease diagnosed in 1 to 3000 livebirths of the Caucasian population. Here a mouse model for this disease is described and optimized using the CFTR-channel selective inhibitor CFTR(inh 172).
Publikováno v:
Journal of Pharmacy and Pharmacology. 65:123-132
Objectives Adenosine is known to induce a bronchospasm in asthma- and COPD patients. The role of A2B receptors was investigated with respect to several parameters of the respiratory tract: tonus of smooth muscle, ciliary beat frequency as measured by
Publikováno v:
Planta Medica. 73:629-635
UNLABELLED Thyme is a broncholytic und secretomotoric agent. Thus, our aim was to investigate the influence of a thyme extract on beta (2)-receptors in competition binding experiments and relaxation experiments on rat uteri and trachea. Furthermore,
Autor:
Gabriela Hanske, Uta Reinke, Marek Matus, Joachim Neumann, Peter Boknik, Frank Begrow, Wilhelm Schmitz, G. Paul Matherne, Isabel Justus
Publikováno v:
Cardiovascular Research. 60:529-537
Objective: The aim of the present study was to assess the effects of A1-adenosine receptor (A1-AR) stimulation in ventricle of A1-adenosine receptor overexpressing mice (transgenic mice, TG). Methods: Effects of the A1-adenosine receptor agonist R-PI
Autor:
Kai C. Wollert, Suzanne M. Lohmann, Frank Begrow, Ulrich Walter, Sevdalina Yurukova, Stepan Gambaryan, Ana Kilic, Michaela Kuhn, Beate Fiedler
Publikováno v:
British Journal of Pharmacology. 140:1227-1236
C-type natriuretic peptide (CNP) and its receptor guanylyl cyclase (GC-B) are expressed in the heart and modulate cardiac contractility in a cGMP-dependent manner. Since the distal cellular signalling pathways remain unclear, we evaluated the peptide
Autor:
Rita Holtwick, Boris V. Skryabin, Frank Begrow, Alexander Bubikat, Hideo A. Baba, Martin van Eickels, Michael D. Schneider, David L. Garbers, Michaela Kuhn
Publikováno v:
Journal of Clinical Investigation. 111:1399-1407
Cardiac hypertrophy is a common and often lethal complication of arterial hypertension. Atrial natriuretic peptide (ANP) has been postulated to exert local antihypertrophic effects in the heart. Thus, a loss of function of the ANP receptor guanylyl c
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 94
Structural modification of the GluN2B selective NMDA receptor antagonist ifenprodil led to the 3-benzazepine WMS-1410 with similar GluN2B affinity but higher receptor selectivity. Herein the in vitro and in vivo biotransformation of WMS-1410 is repor
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 88
The NMDA receptor antagonist ifenprodil is an important lead structure for developing new GluN2B selective NMDA receptor antagonists. Ifenprodil itself has a high affinity to the GluN2B subunit but a poor selectivity for the NMDA receptor. This aspec
Publikováno v:
Planta medica. 78(8)
Silymarin and harpagoside are derived from drugs which are used for their protective effects against hepatotoxicity and inflammatory processes. Both are now investigated with respect to the respiratory tract. They were able to reduce the release of t